Stock Analiz

Definitive Healthcare Corp. DH

Computer Software: Prepackaged Software · IPO 2021 · data as of November 13, 2026

$1.31Market cap $191M
Open the interactive analysis →

Definitive Healthcare Corp. (DH) is a technology company listed in the US with a market value of about $191M. In the twelve months to September 30, 2026 it had revenue of $227M and net income of -$157M, a net margin of -69.2%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (3/5); the weakest is shareholder returns (0/5).

Key numbers: a price to free cash flow of 7.9, 5-year revenue growth of 15% a year, a 5-year average ROIC of -28%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 21% below the current price.

About Definitive Healthcare

Definitive Healthcare is listed in the US and classified in computer software: prepackaged software, IPO year 2021. Revenue went from $118M in 2020 to $242M in 2025, growth of about 15.3% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 5% over three years (dilution for shareholders). It spends 14% of revenue on research and development.

Score: 1.6 / 5

Value1/5
Future growth3/5
Track record1/5
Financial health3/5
Shareholder returns0/5

Checks passed

  • P/FCF below 20
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF7.9
P/S0.8
P/B1.0
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield12.7%
Shareholder yield25.9%
Intrinsic value vs. price−21%

Growth and quality

Revenue growth (1 yr)-4.2%
Revenue growth (5 yrs, per year)15.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)10.8%
Net margin (5-yr avg.)-63.2%
ROIC (5-yr avg.)-27.9%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202520242023202220212020
Revenue$227M$242M$252M$251M$223M$166M$118M
Net income-$157M-$139M-$413M-$202M-$7M-$18M$0
Free cash flow$24M$37M$46M$38M$27M$18M$22M
EPS (diluted)$-1.51$-1.30$-3.54$-1.79$-0.07$-0.19—
Net margin-69.2%-57.5%-163.8%-80.5%-3.2%-10.7%0.0%
ROIC—-38.6%-77.0%-21.1%-1.4%-1.5%-1.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Definitive Healthcare stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 21% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Definitive Healthcare pay a dividend?

Not currently.

Is Definitive Healthcare a good stock to buy?

We do not give buy or sell advice. Definitive Healthcare scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.